These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9154961)

  • 21. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
    Gan TJ; Sinha AC; Kovac AL; Jones RK; Cohen SA; Battikha JP; Deutsch JS; Pergolizzi JV; ; Glass PS
    Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery.
    Aouad MT; Siddik-Sayyid SM; Taha SK; Azar MS; Nasr VG; Hakki MA; Zoorob DG; Baraka AS
    Eur J Anaesthesiol; 2007 Feb; 24(2):171-8. PubMed ID: 16938159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial.
    Walsh T; Morris AK; Holle LM; Callander N; Bradshaw P; Valley AW; Clark G; Freytes CO
    Bone Marrow Transplant; 2004 Dec; 34(11):963-8. PubMed ID: 15489869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granisetron and ondansetron for chemotherapy-related nausea and vomiting.
    Zeidman A; Ben Dayan D; Ben Zion T; Kaufman O; Cohen AM; Mittelman M
    Haematologia (Budap); 1998; 29(1):25-31. PubMed ID: 9704254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.
    Shih V; Wan HS; Chan A
    Ann Pharmacother; 2009 Mar; 43(3):444-52. PubMed ID: 19193584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nausea and vomiting.
    Supportive Oncology Services Inc
    Oncology (Williston Park); 2007 Jul; 21(8 Suppl):2 p following 39. PubMed ID: 17844894
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
    Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A
    J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No more than necessary: safety and efficacy of low-dose promethazine.
    Moser JD; Caldwell JB; Rhule FJ
    Ann Pharmacother; 2006 Jan; 40(1):45-8. PubMed ID: 16352779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the anti-emetic effectiveness of two drug formulations of Ondansetron in combined chemotherapy for children with malignant tumors].
    Safonova SA; Gershanovich ML; Punanov IuA; Kolygin BA
    Vopr Onkol; 1999; 45(4):424-8. PubMed ID: 10532104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma.
    Farber HW; Graven KK; Kokolski G; Korn JH
    J Rheumatol; 1999 May; 26(5):1195-6. PubMed ID: 10332990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dexamethasone plus ondansetron for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a comparison with dexamethasone alone.
    Bano F; Zafar S; Aftab S; Haider S
    J Coll Physicians Surg Pak; 2008 May; 18(5):265-9. PubMed ID: 18541078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ondansetron and dexamethasone dose combinations for prophylaxis against postoperative nausea and vomiting.
    Paech MJ; Rucklidge MW; Lain J; Dodd PH; Bennett EJ; Doherty DA
    Anesth Analg; 2007 Apr; 104(4):808-14. PubMed ID: 17377086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.
    Sarcev T; Secen N; Povazan Dj; Sabo A; Popovic J; Bursac D; Kakas M; Zaric B; Milovancev A
    J BUON; 2007; 12(2):245-52. PubMed ID: 17600880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
    Cabrol S; Souza R; Jais X; Fadel E; Ali RH; Humbert M; Dartevelle P; Simonneau G; Sitbon O
    J Heart Lung Transplant; 2007 Apr; 26(4):357-62. PubMed ID: 17403477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraperitoneal ondansetron hydrochloride for intractable nausea and vomiting due to diabetic gastroparesis in a patient on peritoneal dialysis.
    Amin K; Bastani B
    Perit Dial Int; 2002; 22(4):539-40. PubMed ID: 12322834
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associated adverse events].
    Kodama F; Mohri H; Motomura S; Fukawa H; Tanabe J; Koharasawa H; Kanamori H; Hashimoto Y; Harano H; Sakai R; Tomita N; Fujimaki K; Takemura S; Hattori M
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):273-9. PubMed ID: 11865634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of oral ondansetron syrup or intravenous ondansetron loading dose regimens given in combination with dexamethasone for the prevention of nausea and emesis in pediatric and adolescent patients receiving moderately/highly emetogenic chemotherapy.
    White L; Daly SA; McKenna CJ; Zhestkova N; Leal C; Breatnach F; Smelhaus V; Hung IJ; Kowalczyk J; Ninane J; Mitchell T; Haigh C
    Pediatr Hematol Oncol; 2000 Sep; 17(6):445-55. PubMed ID: 10989464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of ondansetron for prevention of postoperative nausea and vomiting after outpatient ear surgery under local anesthesia.
    Ku PK; Tong MC; Lo P; van Hasselt CA
    Am J Otol; 2000 Jan; 21(1):24-7. PubMed ID: 10651430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
    Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F;
    Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Achieving optimal antiemetic management].
    Krankenpfl J; 2005; 43(7-10):226-7. PubMed ID: 16515295
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.